ESAB Corporation announced a $1 billion senior notes offering that will mature in 2031. The proceeds are earmarked to pay a portion of the purchase price for all issued and outstanding shares of Eddyfi Holding Inc., a $1.45 billion acquisition that expands ESAB’s footprint in the testing‑instrument market.
The new notes add to ESAB’s existing debt, which included a $700 million senior notes issuance due 2029. The combined debt load will increase leverage, but analysts note that the company’s BB+ rating already accounts for the additional $1 billion, and leverage is expected to remain within acceptable limits in the near term.
Strategically, the Eddyfi acquisition is expected to add roughly $270 million in revenue and $80 million in adjusted EBITDA, with potential run‑rate synergies raising the figure to $100 million. The deal also broadens ESAB’s total addressable market by about $5 billion, positioning the company for long‑term growth in a high‑margin segment.
ESAB’s management has emphasized that the notes will provide the liquidity needed to complete the acquisition while preserving flexibility for future capital expenditures and potential acquisitions. The company’s focus on being a “focused premier industrial compounder” is reinforced by this transaction, which aligns with its strategy of organic growth complemented by bolt‑on acquisitions.
The announcement signals ESAB’s confidence in the value of the Eddyfi platform and its ability to manage increased debt without compromising operational performance. Investors will likely view the move as a positive step toward expanding ESAB’s product portfolio and market reach.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.